17Dec/12

How human biology can prevent drug deaths – opinion – 17 December 2012 … – New Scientist

How human biology can prevent drug deaths – opinion – 17 December 2012
New Scientist
For example, in 2006, six people enrolled in a UK trial of the drug TGN1412 were hospitalised after developing multiple organ failure. Many clinical trials are now conducted in India, where, according to India’s Tribune newspaper, at least 1725 people

17Dec/12

Umbilical cord blood establishes blood supply in patients more quickly after … – pharmabiz.com

Umbilical cord blood establishes blood supply in patients more quickly after
pharmabiz.com
Only about 25 per cent of those needing a blood stem cell transplant have a matching donor – the ideal situation for a transplant. Double-cord blood transplant is one of the main options for the rest, which includes a higher proportion of those with
Bad to the BlooddailyRx

all 3 news articles »

17Dec/12

Crunching the Abbott Spinoff Numbers (ABT, ABBV) : Small Cap Diligence – SmallCap Network

Crunching the Abbott Spinoff Numbers (ABT, ABBV) : Small Cap Diligence
SmallCap Network
Daclizumab, bardoxolone (chronic kidney disease), and elotuzumab (multiple myeloma) are all in Phase III trials, with about ten more solid developments in Phase II testing. As for Abbott Laboratories, the device and equipment manufacturer, it’s also a